If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

Share Price is delayed by 15 minutes
Get Live Data
526.00    -4.00 (-0.75%)
Bid:
521.00
Ask:
534.00
Spread: 13.00 (2.495%)
Market Cap: £303.05m
MAB1 Live PriceLast checked at - London Stock Exchange

Intraday Mortgage Advice Bureau Share Chart

Directorate change

1 Jun 2026 14:53

RNS Number : 5160G
Mortgage Advice Bureau (Hldgs) PLC
01 June 2026
Β 

01 June 2026

Mortgage Advice Bureau (Holdings) plc

("MAB" or the "Company")

Directorate Change

Β 

Β 

Mortgage Advice Bureau (Holdings) plc (LSE: MAB1),Β a leading technology-drivenΒ UKΒ property finance service, announces in accordance with UK Listing Rule 6.4.6 that Yaiza Luengo has ceased to be both a director of the Company and Chief Operating Officer with effect from 29 May 2026.

Β 

Enquiries:

Investor Relations investor.relations@mab.org.uk

Β 

Camarco mab@camarco.co.uk

Β 

About MAB:

MAB is a leading UK property finance platform that connects customers, advisers, lenders, and insurers throughout the homeownership journey. Through its scalable, technology-driven intermediary model, MAB delivers personalised mortgage and protection advice via its proprietary platform, supported by deep customer insight and a data-rich, digitally enabled framework.

Β 

Through its partner firms, known as Appointed Representatives (ARs), MAB has over 2,100 advisers providing expert advice across mortgages, specialist lending, protection and general insurance products. MAB supports its AR firms with proprietary technology and services, including adviser recruitment and lead generation, learning and development, compliance auditing and supervision, and digital marketing and website solutions.

Β 

For more information, visitΒ www.mortgageadvicebureau.com

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAUPUUAQUPQGWG
Date   Source Headline
30th Jun 201511:25 amRNSDirector/PDMR Shareholding
29th May 20153:53 pmRNSDirector/PDMR Shareholding
21st May 20155:46 pmRNSGrants of Options to Appointed Representatives
20th May 20154:09 pmRNSGrant of Options
20th May 20152:37 pmRNSDirector/PDMR Shareholding
20th May 20152:35 pmRNSResult of AGM
20th May 20157:00 amRNSAGM Statement
5th May 20155:24 pmRNSCancellation of Shares
29th Apr 20155:05 pmRNSDirectors' Shareholdings
2nd Apr 20151:19 pmRNSDirector/PDMR Shareholding
31st Mar 201511:25 amRNSDirector/PDMR Shareholding
27th Mar 20157:00 amRNSDividend Declaration
26th Mar 20157:32 amRNSFinal Results and Board Changes
27th Feb 201511:50 amRNSDirector/PDMR Shareholding
30th Jan 20154:17 pmRNSDirector/PDMR Shareholding
23rd Jan 20157:00 amRNSPre-close Trading Update
30th Dec 20146:37 pmRNSDirector/PDMR Shareholding
2nd Dec 20142:51 pmRNSDirectors' Shareholdings
1st Dec 20147:00 amRNSDirectors Shareholdings
17th Nov 20145:22 pmRNSHolding(s) in Company
17th Nov 20141:58 pmRNSHolding(s) in Company
17th Nov 201411:40 amRNSHolding(s) in Company
14th Nov 20141:06 pmRNSHolding(s) in Company
14th Nov 20147:00 amRNSAdmission to trading on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.